Literature DB >> 8518054

Angiotensin converting enzyme inhibitors in heart failure: how good are they?

J N Townend1, W A Littler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8518054      PMCID： PMC1025093          DOI： 10.1136/hrt.69.5.373

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  18 in total

1.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

2.  Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.

Authors:  B L Kramer; B M Massie; N Topic
Journal:  Circulation       Date:  1983-04       Impact factor: 29.690

3.  Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure.

Authors:  J A Franciosa; M M Wilen; R A Jordan
Journal:  J Am Coll Cardiol       Date:  1985-01       Impact factor: 24.094

4.  Captopril in heart failure. A double blind controlled trial.

Authors:  J G Cleland; H J Dargie; G P Hodsman; S G Ball; J I Robertson; J J Morton; B W East; I Robertson; G D Murray; G Gillen
Journal:  Br Heart J       Date:  1984-11

5.  Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol.

Authors:  W S Colucci; R W Alexander; G H Williams; R E Rude; B L Holman; M A Konstam; J Wynne; G H Mudge; E Braunwald
Journal:  N Engl J Med       Date:  1981-07-23       Impact factor: 91.245

6.  Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.

Authors:  D N Sharpe; J Murphy; R Coxon; S F Hannan
Journal:  Circulation       Date:  1984-08       Impact factor: 29.690

7.  Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle exercise in chronic heart failure. Comparison of graphical methods, interobserver variability and influence of the exercise protocol. The VO2 French Study Group.

Authors:  A Cohen-Solal; F Zannad; J G Kayanakis; P Gueret; J F Aupetit; H Kolsky
Journal:  Eur Heart J       Date:  1991-10       Impact factor: 29.983

8.  Prenatal diagnosis of congenital rubella.

Authors:  F Daffos; F Forestier; L Grangeot-Keros; M Capella Pavlovsky; P Lebon; M Chartier; J Pillot
Journal:  Lancet       Date:  1984-07-07       Impact factor: 79.321

9.  Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.

Authors:  J A Franciosa; K T Weber; T B Levine; G T Kinasewitz; J S Janicki; J West; M M Henis; J N Cohn
Journal:  Am Heart J       Date:  1982-09       Impact factor: 4.749

10.  Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.

Authors:  G A Riegger
Journal:  Eur Heart J       Date:  1991-06       Impact factor: 29.983
View more
  5 in total

1.  Hibernating myocardium in post-ischaemic heart failure: pathophysiology, identification and revascularisation.

Authors:  D Pagano
Journal:  Ann R Coll Surg Engl       Date:  2000-07       Impact factor: 1.891

Review 2.  Coronary artery disease, valvular heart disease, bradycardia, and heart failure.

Authors:  E Smith; H Powell; I R Hastie
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

3.  Coronary revascularisation for postischaemic heart failure: how myocardial viability affects survival.

Authors:  D Pagano; M E Lewis; J N Townend; P Davies; P G Camici; R S Bonser
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

Review 4.  When to start an ACE inhibitor and in whom.

Authors:  P A Wilson
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

5.  ACE for whom? Implications for clinical practice of post-infarct trials.

Authors:  J T Walsh; D Gray; N A Keating; A J Cowley; J R Hampton
Journal:  Br Heart J       Date:  1995-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.